NOS3 and Hyperglycemia: RhoA activation (due to hyperglycemia or high glucose treatment) suppresses eNOS activity by reducing the phosphorylation of the eNOS stimulatory site (Ser 117) and enhancing the phosphorylation of its inhibitory site (Ser 495); the effect is reversed by G1 and E2-mediated GPER stimulation [42].